Correlation Between JPMorgan Chase and Zentalis Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both JPMorgan Chase and Zentalis Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining JPMorgan Chase and Zentalis Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between JPMorgan Chase Co and Zentalis Pharmaceuticals Llc, you can compare the effects of market volatilities on JPMorgan Chase and Zentalis Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in JPMorgan Chase with a short position of Zentalis Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of JPMorgan Chase and Zentalis Pharmaceuticals.
Diversification Opportunities for JPMorgan Chase and Zentalis Pharmaceuticals
-0.32 | Correlation Coefficient |
Very good diversification
The 3 months correlation between JPMorgan and Zentalis is -0.32. Overlapping area represents the amount of risk that can be diversified away by holding JPMorgan Chase Co and Zentalis Pharmaceuticals Llc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Zentalis Pharmaceuticals and JPMorgan Chase is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on JPMorgan Chase Co are associated (or correlated) with Zentalis Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Zentalis Pharmaceuticals has no effect on the direction of JPMorgan Chase i.e., JPMorgan Chase and Zentalis Pharmaceuticals go up and down completely randomly.
Pair Corralation between JPMorgan Chase and Zentalis Pharmaceuticals
Considering the 90-day investment horizon JPMorgan Chase Co is expected to generate 0.25 times more return on investment than Zentalis Pharmaceuticals. However, JPMorgan Chase Co is 4.05 times less risky than Zentalis Pharmaceuticals. It trades about 0.1 of its potential returns per unit of risk. Zentalis Pharmaceuticals Llc is currently generating about -0.05 per unit of risk. If you would invest 11,939 in JPMorgan Chase Co on July 21, 2024 and sell it today you would earn a total of 10,598 from holding JPMorgan Chase Co or generate 88.77% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
JPMorgan Chase Co vs. Zentalis Pharmaceuticals Llc
Performance |
Timeline |
JPMorgan Chase |
Zentalis Pharmaceuticals |
JPMorgan Chase and Zentalis Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with JPMorgan Chase and Zentalis Pharmaceuticals
The main advantage of trading using opposite JPMorgan Chase and Zentalis Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if JPMorgan Chase position performs unexpectedly, Zentalis Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Zentalis Pharmaceuticals will offset losses from the drop in Zentalis Pharmaceuticals' long position.JPMorgan Chase vs. Bank of Montreal | JPMorgan Chase vs. KBC Groep NV | JPMorgan Chase vs. X4 Pharmaceuticals | JPMorgan Chase vs. Davis Select Financial |
Zentalis Pharmaceuticals vs. KBC Groep NV | Zentalis Pharmaceuticals vs. Pfizer Inc | Zentalis Pharmaceuticals vs. JPMorgan Chase Co | Zentalis Pharmaceuticals vs. Davis Select Worldwide |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Complementary Tools
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |